Article Data

  • Views 3096
  • Dowloads 208

Case Reports

Open Access

Severe invasive disease caused by hypervirulent Klebsiella pneumoniae: a case report

  • Qingdong Li1
  • Yongli Zhang1

1Department of Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, P. R. China

DOI: 10.22514/sv.2021.052 Vol.18,Issue 2,March 2022 pp.159-163

Submitted: 07 January 2021 Accepted: 20 February 2021

Published: 08 March 2022

*Corresponding Author(s): Yongli Zhang E-mail: zylicu@163.com

Abstract

Klebsiella pneumoniae (K. pneumoniae) is a common pathogenic bacteria that causes numerous infectious diseases. Hypervirulent K. pneumoniae (hvKP) can lead to invasive K. pneumoniae liver abscess syndrome, which can induce life-threatening multiple organ dysfunction syndrome or septic shock. We report a case of invasive K. pneumoniae liver abscess syndrome caused by hvKP and discuss the treatment options of this syndrome. Appropriate antimicrobial drugs should be administered to improve prognosis and prevent complications, and laboratory testing is essential to guide clinical management and optimize patient outcomes.


Keywords

Hypervirulent Klebsiella pneumonia; Antimicrobial therapy; Prognosis; Case report


Cite and Share

Qingdong Li,Yongli Zhang. Severe invasive disease caused by hypervirulent Klebsiella pneumoniae: a case report. Signa Vitae. 2022. 18(2);159-163.

References

[1] Qian Y, Wong CC, Lai S, Chen H, He X, Sun L, et al. A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015. Scientific Reports. 2016; 6: 38587.

[2] Lee H, Chuang Y, Yu W, Lee N, Chang C, Ko N, et al. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. Journal of Internal Medicine. 2006; 259: 606-614.

[3] Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, et al. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimi-crobial Agents and Chemotherapy. 2016; 60: 6115-6120.

[4] Van Keer J, Van Keer K, Van Calster J, Derdelinckx I. More than meets the eye: Klebsiella pneumoniae invasive liver abscess syndrome presenting with endophthalmitis. The Journal of Emergency Medicine. 2017; 52: e221-e223.

[5] Namikawa H, Yamada K, Fujimoto H, Oinuma K, Tochino Y, Takemoto Y, et al. Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome. BMC Infectious Diseases. 2016; 16: 680.

[6] Guo Y, Wang S, Zhan L, Jin Y, Duan J, Hao Z, et al. Microbiological and clinical characteristics of hypermucoviscous Klebsiella pneumoniae isolates associated with invasive infections in China. Frontiers in Cellular and Infection Microbiology. 2017; 7: 24.

[7] Wang B, Zhang P, Li Y, Wang Y. Klebsiella pneumoniae-induced multiple invasive abscesses. Medicine. 2019; 98: e17362.

[8] Bradley ME, Scoular SK. Metastatic Klebsiella pneumoniae invasive liver abscess syndrome in Denver, Colorado. Journal of Pharmacy Practice. 2019; 897190019882867.

[9] Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology. 2018; 8: 4.

[10] Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, et al. Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio. 2015; 6: e00630.

[11] Siu LK, Yeh K, Lin J, Fung C, Chang F. Klebsiella pneumoniae liver abscess: a new invasive syndrome. The Lancet Infectious Diseases. 2012; 12: 881-887.

[12] Hyun M, Lee JY, Ryu S, Ryoo N, Kim HA. Antibiotic resistance and clinical presentation of health care-associated hypervirulent Klebsiella pneumoniae infection in Korea. Microbial Drug Resistance. 2019; 25: 1204-1209.

[13] Ge F, Parker J, Chul Choi S, Layer M, Ross K, Jilly B, et al. Preferential amplification of pathogenic sequences. Scientific Reports. 2015; 5: 11047.

[14] Chew KL, Lin RTP, Teo JWP. Klebsiella pneumoniae in Singapore: hypervirulent Infections and the Carbapenemase threat. Frontiers in Cellular and Infection Microbiology. 2017; 7: 515.

[15] Siu LK, Yeh K, Lin J, Fung C, Chang F. Klebsiella pneumoniae liver abscess: a new invasive syndrome. The Lancet. Infectious Diseases. 2012; 12: 881-887.

[16] Sturm E, Tai A, Lin B, Kwong J, Athan E, Howden BP, et al. Bilateral osteomyelitis and liver abscess caused by hypervirulent Klebsiella pneumoniae- a rare clinical manifestation (case report). BMC Infectious Diseases. 2018; 18: 380.

[17] Setsu T, Tsuchiya A, Yamagiwa S, Terai S. Invasive liver abscess syndrome caused by Klebsiella pneumoniae. Internal Medicine. 2017; 56: 3121-3122.

[18] Chen Y, Li Y, Lin Y, Chen Y, Wang N, Chao A, et al. Prognostic factors and visual outcomes of pyogenic liver abscess-related endogenous Klebsiella pneumoniae endophthalmitis: a 20-year retrospective review. Scientific Reports. 2019; 9: 1071.

[19] Li Y, Chen Y, Chen K, Wang N, Sun M, Chao A, et al. Infectious sources, prognostic factors, and visual outcomes of endogenous Klebsiella pneumoniae endophthalmitis. Ophthalmology Retina. 2018; 2: 771-778.

[20] Chen S, Lee Y, Chen Y, Lin H, Wu T, Sheu S. Klebsiella pneumoniae infection leads to a poor visual outcome in endogenous endophthalmitis: a 12-year experience in southern Taiwan. Ocular Immunology and Inflammation. 2017; 25: 870-877.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.3 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top